Song Hyun Jin, Seo Hyun-Ju, Lee Youngjin, Kim Sung Kyu
College of Pharmacy, University of Florida, Gainesville, FL.
Department of Nursing, College of Medicine, Chosun University, Gwangju.
Medicine (Baltimore). 2018 Dec;97(51):e13126. doi: 10.1097/MD.0000000000013126.
Although high-intensity laser therapy (HILT) has been used for the management of musculoskeletal disorders (MSD), studies examining the effectiveness of HILT have been limited. We investigated the effectiveness of HILT in MSD using a systematic review and meta-analysis.
We searched the ovid MEDLINE, ovid Embase, Cochrane CENTRAL library, and Web of Science until January, 2018. Relevant studies concerning the effectiveness of HILT in patients with MSD were included. Both placebo and active controls were considered as comparators and only randomized controlled trial (RCT) design studies were included. Risk of bias (ROB) was used for the quality assessment of the RCT. For continuous variables, a meta-analysis was conducted using an inverse variance random effects model. The mean difference (MD) for visual analog scale pain and standardized mean difference (SMD) for disability were applied.
Twelve studies were selected for this systematic review. In 11 studies, comprising 736 patients, pain was significantly improved by HILT compared with a control group (MD: -1.01; 95% confidence interval [CI]: -1.28 to -0.74). From the analysis of 688 patients from 10 studies, the pooled standardized mean difference (SMD) of HILT showed a significant improvement in disability scores compared with those in the control group (SMD, -1.09; 95% CI -1.77, -0.41). In subgroup analysis by treatment regions, the mean difference (MD) in neck pain was the highest at -1.02 (95% CI: -1.45, -0.58) than in controls, followed by back pain (MD, -0.91; 95% CI: -1.24, -0.59).
The results of this study show that HILT treatment for back and neck pain significantly improved pain and disability scores compared with controls. The ROB of the included studies was moderate; however, significant heterogeneity existed. Thus, additional well-designed studies involving larger samples with long-term follow-up are needed to further assess each laser application, treatment region, and comparator.
尽管高强度激光疗法(HILT)已用于肌肉骨骼疾病(MSD)的治疗,但检验HILT有效性的研究有限。我们通过系统评价和荟萃分析研究了HILT在MSD中的有效性。
我们检索了ovid MEDLINE、ovid Embase、Cochrane CENTRAL图书馆和Web of Science直至2018年1月。纳入了有关HILT对MSD患者有效性的相关研究。安慰剂和活性对照均被视为对照,仅纳入随机对照试验(RCT)设计的研究。采用偏倚风险(ROB)对RCT进行质量评估。对于连续变量,使用逆方差随机效应模型进行荟萃分析。应用视觉模拟量表疼痛的平均差(MD)和残疾的标准化平均差(SMD)。
12项研究被选入本系统评价。在11项研究(共736例患者)中,与对照组相比,HILT显著改善了疼痛(MD:-1.01;95%置信区间[CI]:-1.28至-0.74)。对10项研究中的688例患者进行分析,与对照组相比,HILT的合并标准化平均差(SMD)显示残疾评分有显著改善(SMD,-1.09;95%CI -1.77,-0.41)。在按治疗部位进行的亚组分析中,颈部疼痛的平均差(MD)最高,为-1.02(95%CI:-1.45,-0.58),高于对照组,其次是背部疼痛(MD,-0.91;95%CI:-1.24,-0.59)。
本研究结果表明,与对照组相比,HILT治疗背部和颈部疼痛显著改善了疼痛和残疾评分。纳入研究的ROB为中度;然而,存在显著异质性。因此,需要进一步开展设计良好、样本量更大且有长期随访的研究,以进一步评估每种激光应用、治疗部位和对照。